Bilayer Therapeutics logo

Bilayer Therapeutics

Developing innovative treatments for GI disease and metabolic disorders (obesity & diabetes) based on GLP-1 and TGR5

1 employees · est. 2020 · Cambridge, United States

VS
Energesis Pharmaceuticals logo

Energesis Pharmaceuticals

Pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure.

2 employees · est. 2009

Energesis Pharmaceuticals is the older company (2020 vs 2009); Energesis Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Bilayer Therapeutics Energesis Pharmaceuticals
Founded
2020 2009 older
Headquarters
Cambridge, United States Not tracked yet
Employees
1 2 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Series Unknown Grant
Total Funding
$2.00M $150.00K
Funding Rounds
1 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
GI Disease, Metabolic Disorders, Obesity, Diabetes, GLP-1, TGR5, Bilayer Tablet Technology, Drug Development, Bile Acid, Motility Disorders, Chronic Constipation, Innovative Treatments, First-in-class Treatments, Drug Candidate Biopharmaceutical, Obesity Treatment, Diabetes Treatment, Metabolic Conditions, Drug Discovery, Energy Expenditure, Weight Management, Innovative Drugs, Metabolic Diseases, Pharmaceutical Company
Website
bilayer-therapeutics.com energesispharma.com
Bilayer Therapeutics logo

About Bilayer Therapeutics

Bilayer Therapeutics is a development-stage company focused on pioneering treatments for gastrointestinal (GI) disease and metabolic disorders such as obesity and diabetes. The company's approach utilizes GLP-1 and TGR5 - regulatory mechanisms for metabolism and motility. Founded in 2020 by a team o...

Energesis Pharmaceuticals logo

About Energesis Pharmaceuticals

Energesis Pharmaceuticals is a biotechnology startup that was founded in 2009. The company is focused on pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure. Unlike traditional approaches that mainly tackle the intake side of weight management, Ener...

We will tell you when either one moves

BounceWatch watches Bilayer Therapeutics and Energesis Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Bilayer Therapeutics and Energesis Pharmaceutic... — by email.

Frequently Asked Questions

Bilayer Therapeutics — Developing innovative treatments for GI disease and metabolic disorders (obesity & diabetes) based on GLP-1 and TGR5 . Energesis Pharmaceuticals — Pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Bilayer Therapeutics has raised $2.00M while Energesis Pharmaceuticals has raised $150.00K.
Bilayer Therapeutics and Energesis Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Bilayer Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Bilayer Therapeutics on 12 Sep 2024, and Energesis Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes